Case Control Study
Copyright ©The Author(s) 2022.
World J Crit Care Med. May 9, 2022; 11(3): 139-148
Published online May 9, 2022. doi: 10.5492/wjccm.v11.i3.139
Table 1 The control and patients' demographic and clinical and laboratory data

Control group (n = 30)
EOS group (n = 30)
LOS group (n = 30)
t/Z
P value
Age (mean ± SD, d)2.10 ± 0.82.47 ± 0.5712.47 ± 4.03147.0240.001
Weight (mean ± SD, g)2.98 ± 0.42.85 ± 0.412.95 ± 0.30.895NS
Male: Female0.9:10.87: 11.5:10.356 NS
% of cesarean section 23 (76.7%)22 (73.3%)21 (70%)0.381NS
PROM06 (20%)0
Risk factors (invasive procedure)UVC04 (13.3%)00.001
ETT05 (16.7%)4 (13.3%)0.001
UVC + ETT07 (23.3%)13 (43.3%)0.001
None100%14 (46.7%)13 (43.3%)0.001
Respiratory distress027 (90%)23 (77%)1.920NS
Apnea03 (10%)3 (10%)FENS
Cyanosis010 (33.3%)14 (46.7%)1.111NS
Positive Gerdes score (≥ 2)022 (73.3%)19 (63.3 %)38.2580.001
Thrombocytopenia2 (6.7%)22 (73%)12 (40%)6.7870.009
CRP (mg/dL)4 ± 257.53 ± 38.8265.47 ± 39.620.783NS
D-dimer (mg/L)0.60 ± 0.701.48 ± 1.442.27 ± 1.8610.5120.001
Hospital duration021.6 ± 1022 ± 90.051NS
Mortality 09 (30%)11 (36.7%)0.300 NS